Cargando…
Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
Pediatric acute myeloid leukemia (AML) is a heterogeneous disease and remains clinically challenging. Currently chemotherapies are frequently associated with treatment-related death and long-term side effects. Therefore, alternative approaches with lower toxicity are highly desired. Ginsenosides and...
Autores principales: | Chen, Yan, Xu, Yajing, Zhu, Yan, Li, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602037/ https://www.ncbi.nlm.nih.gov/pubmed/23497352 http://dx.doi.org/10.1186/1475-2867-13-24 |
Ejemplares similares
-
Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays
por: Yan-Fang, Tao, et al.
Publicado: (2012) -
Anti-cancer effects of ginsenoside CK on acute myeloid leukemia in vitro and in vivo
por: Hou, Yuzhu, et al.
Publicado: (2022) -
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021) -
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia
por: Yin, Xuejiao, et al.
Publicado: (2018) -
CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells
por: Wei, Xiao-Fang, et al.
Publicado: (2018)